Advertisement
U.S. markets close in 2 hours 9 minutes

Kura Oncology, Inc. (KURA)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Visitors trend2W10W9M
10.99+0.19 (+1.81%)
As of 01:51PM EST. Market open.
Advertisement
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
0
0
0
0
0
Operating Expense
217,502
165,804
139,865
131,258
91,899
Operating Income
-217,502
-165,804
-139,865
-131,258
-91,899
Net Non Operating Interest Income Expense
19,950
13,173
4,025
792
2,274
Other Income Expense
-
-
-
-
51
Pretax Income
-197,552
-152,631
-135,840
-130,466
-89,625
Net Income Common Stockholders
-197,552
-152,631
-135,840
-130,466
-89,625
Diluted NI Available to Com Stockholders
-197,552
-152,631
-135,840
-130,466
-89,625
Basic EPS
-2.02
-2.08
-2.03
-1.97
-1.69
Diluted EPS
-2.02
-2.08
-2.03
-1.97
-1.69
Basic Average Shares
70,832
73,229
66,990
66,352
53,077
Diluted Average Shares
70,832
73,229
66,990
66,352
53,077
Total Expenses
217,502
165,804
139,865
131,258
91,899
Net Income from Continuing & Discontinued Operation
-197,552
-152,631
-135,840
-130,466
-89,625
Normalized Income
-197,552
-152,631
-135,840
-130,466
-89,625
Interest Income
21,560
14,722
4,254
1,206
2,852
Interest Expense
1,610
1,549
229
414
578
Net Interest Income
19,950
13,173
4,025
792
2,274
EBIT
-195,942
-151,082
-135,611
-130,052
-89,047
EBITDA
-195,084
-150,233
-134,852
-129,494
-88,853
Reconciled Depreciation
858
849
759
558
194
Net Income from Continuing Operation Net Minority Interest
-197,552
-152,631
-135,840
-130,466
-89,625
Total Unusual Items Excluding Goodwill
-
-
-
-
0
Total Unusual Items
-
-
-
-
0
Normalized EBITDA
-195,084
-150,233
-134,852
-129,494
-88,853
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0